Cargando…
Duloxetine in the treatment of stress urinary incontinence
Stress urinary incontinence (SUI) is the most common form of urinary incontinence and occurs more frequently in women than in men. Duloxetine is a balanced dual serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor and shows no relevant binding affinity for histaminergic, dopaminergic, choline...
Autores principales: | Jost, Wolfgang H, Marsalek, Parvaneh |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661641/ https://www.ncbi.nlm.nih.gov/pubmed/18360568 |
Ejemplares similares
-
Update on duloxetine for the management of stress urinary incontinence
por: Basu, Maya, et al.
Publicado: (2009) -
Evaluation of efficacy of duloxetine in stress urinary incontinence in women
por: Deepak, P., et al.
Publicado: (2011) -
Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial
por: Lin, Alex Tong-Long, et al.
Publicado: (2008) -
Pelvic floor muscle exercise with or without duloxetine for postprostatectomy urinary incontinence: A retrospective single-center study
por: Kang, Chang Seok, et al.
Publicado: (2023) -
The treatment of female stress urinary incontinence: an evidenced-based review
por: Cameron, Anne P, et al.
Publicado: (2011)